IU studies find breakthrough diabetes link
A psoriasis drug taken off the market in 2011 has been found to decrease negative effects of Type 1 diabetes. Researchers at IU School of Medicine recently published a report on the interaction between the drug and the disease, and patients are all expected to have completed the study by next spring.








